查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679370

核酸甲基化市場規模、佔有率、趨勢分析報告：按產品/服務、類型、技術、應用、最終用途、地區、細分預測，2025-2030 年

Nucleic Acid Methylation Market Size, Share & Trends Analysis Report By Product & Services (Kits & Reagents, Enzymes), By Type (DNA Methylation, RNA Methylation), By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

核酸甲基化市場的成長與趨勢

根據 Grand View Research, Inc. 的一份新報告，全球核酸甲基化市場預計到 2030 年將達到 77.7 億美元，預測期內的複合年成長率為 14.69%。

這一市場受到早期疾病檢測需求的不斷成長、測序技術的進步以及精準醫療的日益普及的推動。對錶觀遺傳學、癌症診斷和神經系統疾病的研究日益增多，推動了市場擴張。人工智慧主導的生物資訊學、經濟高效的NGS和質譜分析正在提高資料分析和效率。此外，製藥和生物技術公司不斷增加的投資以及政府對錶觀遺傳學研究的資助正在刺激創新。藥物研發、個人化醫療和非侵入性診斷領域的應用不斷擴大，進一步促進了市場的成長。

COVID-19 疫情加速了市場的發展，增加了對病毒表觀遺傳學、免疫反應和生物標記發現的研究。這推動了對先進測序技術、人工智慧主導的資料分析和精準醫療的需求。此外，政府資金和製藥公司對分子診斷和藥物開發的投資不斷增加，進一步推動了基於甲基化的研究和臨床應用。這些因素正在推動市場的成長，預計在預測期內市場將呈指數級成長。

此外，人工智慧的整合有望透過增強資料分析、改善生物標記發現和簡化定序工作流程來推動市場成長。人工智慧生物資訊學將能夠更快、更準確地解釋甲基化模式，支援早期疾病檢測和個人化醫療。此外，人工智慧自動化將降低研究成本、提高效率、加速藥物發現，進一步促進市場擴張。預計這將對預測期內的市場成長產生積極影響。

高成本和技術複雜性給市場帶來了重大挑戰。先進的定序平台、生物資訊工具和甲基化檢測需要大量投資，因此小型實驗室和新興市場難以獲得它們。此外，對熟練人力、高級資料分析和昂貴試劑的需求進一步增加了營運成本。儘管自動化和人工智慧主導的生物資訊解決方案的整合提高了效率，但可負擔性仍然是廣泛採用的障礙，阻礙了預測期內的市場成長。

核酸甲基化市場報告重點

  • 2024 年，套件和試劑領域佔據最大的市場佔有率，為 34.89%，這得益於其在甲基化分析中的廣泛應用、對錶觀遺傳研究的不斷成長的需求、測序技術的進步以及對經濟高效且高度準確的診斷解決方案的需求。另一方面，預計服務業在預測期內將以最快的複合年成長率成長。
  • DNA 甲基化領域在 2024 年佔據了最大的市場佔有率，因為它在疾病診斷、癌症研究和藥物開發中發揮著至關重要的作用。採用 DNA 甲基化生物標記進行早期檢測、定序技術的進步以及對錶觀遺傳學研究的投資增加進一步促進了市場主導地位。另一方面，RNA甲基化預計在預測期內以最快的複合年成長率成長。
  • 2024 年，次世代定序 (NGS) 領域預計將引領技術市場並以最快的複合年成長率 (2025-2030) 成長，這得益於其在分析 DNA 和 RNA 甲基化模式方面的高準確性、可擴展性和效率。癌症研究、表觀遺傳學研究和精準醫療中越來越多的應用、人工智慧生物資訊學的進步以及測序成本的下降正在推動這項技術的快速發展。預計亞硫酸氫鹽測序和基於 PCR 的技術領域將在預測期內顯著成長。
  • 藥物發現和個人化醫療領域預計將在 2024 年佔據應用市場的主導地位，這得益於其在分析 DNA 和 RNA 甲基化模式方面的高準確性、可擴展性和效率。癌症研究、表觀遺傳學研究和精準醫療的應用日益廣泛、人工智慧生物資訊學的進步以及測序成本的下降正在推動這一領域的快速成長。另一方面，臨床診斷預計在預測期內將以最快的複合年成長率成長。
  • 由於在藥物發現、生物標記研究和精準醫療方面投入了大量資金，製藥和生物技術公司部門在 2024 年佔據了終端市場主導地位。基於甲基化的技術在標靶治療開發中的應用日益廣泛，再加上定序和人工智慧主導的資料分析的進步，進一步加強了其市場主導。另一方面，預計醫院和診斷實驗室在預測期內將以最快的複合年成長率成長。
  • 預計到 2024 年，北美地區將佔據市場主導地位，佔有 40.46% 的佔有率，這得益於對錶觀遺傳學研究的強勁投資、先進的醫療基礎設施以及精準醫療的廣泛應用。主要生物技術和製藥公司的存在，以及對基於甲基化的診斷的監管支持，進一步推動了該地區市場的成長。預計亞太地區在預測期內的複合年成長率最快。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 核酸甲基化市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 核酸甲基化市場分析工具
    • 產業分析 – 波特五力分析
    • PESTEL 分析
    • COVID-19影響分析

第4章核酸甲基化市場：按產品/服務的估計和趨勢分析

  • 產品/服務細分儀表板
  • 全球核酸甲基化市場產品與服務變化分析
  • 2018-2030年全球核酸甲基化市場規模及趨勢分析（依產品及服務）
  • 套件和試劑
  • 酵素
  • 服務
  • 設備和軟體
  • 耗材

第5章核酸甲基化市場：按類型估計和趨勢分析

  • 類型細分儀表板
  • 全球核酸甲基化市場類型變化分析
  • 2018-2030年全球核酸甲基化市場規模及趨勢分析（依類型）
  • DNA甲基化
  • RNA甲基化

第6章核酸甲基化市場：依技術、估計和趨勢分析

  • 技術細分儀表板
  • 全球核酸甲基化市場技術變遷分析
  • 2018-2030年全球核酸甲基化市場規模及趨勢分析（依技術）
  • 新一代定序（NGS）
  • 亞硫酸氫鹽測序和基於PCR的技術
  • 基於微陣列的甲基化分析
  • 質譜法
  • 基於雜合反應和基於抗體的檢測

第7章核酸甲基化市場：應用預測與趨勢分析

  • 應用程式細分儀表板
  • 全球核酸甲基化市場應用變化分析
  • 2018-2030年全球核酸甲基化市場規模及應用趨勢分析
  • 藥物研發與個人化醫療
  • 臨床診斷
  • 其他

第8章核酸甲基化市場：依最終用途的估計和趨勢分析

  • 最終用途細分儀表板
  • 全球核酸甲基化市場最終用途變化分析
  • 2018-2030年全球核酸甲基化市場規模及最終用途趨勢分析
  • 製藥和生物技術公司
  • 學術研究所
  • 醫院和診斷實驗室

第 9 章核酸甲基化市場：按產品/服務、類型、技術、應用、最終用途、區域、估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章 競爭格局

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 公司簡介/上市公司
    • New England Biolabs
    • Thermo Fisher Scientific Inc.
    • Illumina Inc.
    • Abcam plc
    • Agilent Technologies Inc.
    • F. Hoffmann-La Roche Ltd
    • Bio-Rad Laboratories, Inc.
    • QIAGEN
    • Exact Sciences Corporation
    • Diagenode Diagnostics SA
Product Code: GVR-4-68040-524-6

Nucleic Acid Methylation Market Growth & Trends:

The global nucleic acid methylation market is anticipated to reach USD 7.77 billion by 2030 and is projected to grow at a CAGR of 14.69% during the forecast period, according to a new report by Grand View Research, Inc. The market is driven by increasing demand for early disease detection, advancements in sequencing technologies, and growing adoption of precision medicine. Rising research in epigenetics, cancer diagnostics, and neurological disorders is fueling market expansion. AI-driven bioinformatics, cost-effective NGS, and mass spectrometry are enhancing data analysis and efficiency. In addition, increasing investments from pharmaceutical and biotech companies, along with government funding for epigenetics research, are accelerating innovation. Expanding applications in drug discovery, personalized medicine, and non-invasive diagnostics further contribute to market growth.

The COVID-19 pandemic accelerated the market by increasing research in viral epigenetics, immune response, and biomarker discovery. It drove demand for advanced sequencing technologies, AI-driven data analysis, and precision medicine. In addition, increased government funding and pharmaceutical investments in molecular diagnostics and drug development further boosted the adoption of methylation-based research and clinical applications. These factors have propelled the growth of the market and are anticipated to propel exponentially over the forecast period.

Moreover, AI integration is anticipated to propel market growth by enhancing data analysis, improving biomarker discovery, and streamlining sequencing workflows. AI-driven bioinformatics enables faster and more accurate interpretation of methylation patterns, supporting early disease detection and personalized medicine. In addition, AI-powered automation reduces research costs, increases efficiency, and accelerates drug discovery, further driving market expansion. Thereby expected to positively impact the growth of the market over the forecast period.

High costs and technical complexity pose significant challenges to the market. Advanced sequencing platforms, bioinformatics tools, and methylation assays require substantial investment, making them less accessible to smaller research labs and emerging markets. In addition, the need for highly skilled personnel, sophisticated data analysis, and expensive reagents further increases operational costs. The integration of automation and AI-driven bioinformatics solutions is improving efficiency, but affordability remains a barrier to widespread adoption, thereby hampering the growth of the market over the forecast period.

Nucleic Acid Methylation Market Report Highlights:

  • The kits & reagents segment held the largest market share of 34.89% in 2024 due to their widespread use in methylation analysis, growing demand for epigenetic research, advancements in sequencing technologies, and the need for cost-effective, high-precision diagnostic solutions. On the other hand, services are expected to grow at the fastest CAGR over the forecast period.
  • The DNA methylation segment held the largest market share in 2024 due to its crucial role in disease diagnostics, cancer research, and drug development. Growing adoption of DNA methylation biomarkers for early detection, advancements in sequencing technologies, and increasing investment in epigenetics research have further driven its market dominance. On the other hand, RNA methylation is expected to grow at the fastest CAGR over the forecast period.
  • In 2024, the next-generation sequencing (NGS) segment is expected to lead the technology market and grow at the fastest CAGR (2025-2030) due to its high accuracy, scalability, and efficiency in analyzing DNA and RNA methylation patterns. Increasing adoption in cancer research, epigenetics studies, and precision medicine, along with advancements in AI-driven bioinformatics and decreasing sequencing costs, are driving its rapid growth. The bisulfite sequencing & PCR-based techniques segment is expected to grow significantly over the forecast period.
  • In 2024, the drug discovery & personalized medicines segment is expected to dominate the application market due to its high accuracy, scalability, and efficiency in analyzing DNA and RNA methylation patterns. Increasing adoption in cancer research, epigenetics studies, and precision medicine, along with advancements in AI-driven bioinformatics and decreasing sequencing costs, are driving its rapid growth. On the other hand, clinical diagnostics are expected to grow at the fastest CAGR over the forecast period.
  • The pharmaceutical & biotechnological companies segment dominated the end use market in 2024 due to their significant investment in drug discovery, biomarker research, and precision medicine. The growing use of methylation-based technologies for developing targeted therapies, coupled with advancements in sequencing and AI-driven data analysis, has further strengthened their market leadership. On the other hand, hospitals & diagnostic laboratories are expected to grow at the fastest CAGR over the forecast period.
  • The North America region dominated the market with a 40.46% share in 2024, driven by strong investments in epigenetics research, advanced healthcare infrastructure, and widespread adoption of precision medicine. The presence of leading biotechnology and pharmaceutical companies, along with regulatory support for methylation-based diagnostics, has further fueled market growth in the region. Asia Pacific is anticipated to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Services
    • 1.2.2. Type
    • 1.2.3. Technology
    • 1.2.4. Application
    • 1.2.5. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Nucleic Acid Methylation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising demand for epigenetic biomarkers
      • 3.2.1.2. RNA methylation as a drug target
      • 3.2.1.3. Advancements in high-throughput methylation analysis
      • 3.2.1.4. Government & private investments in epigenetics
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High costs & technical complexity
  • 3.3. Nucleic Acid Methylation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Nucleic Acid Methylation Market: Product & Services Estimates & Trend Analysis

  • 4.1. Product & Services Segment Dashboard
  • 4.2. Global Nucleic Acid Methylation Market Product & Services Movement Analysis
  • 4.3. Global Nucleic Acid Methylation Market Size & Trend Analysis, by Product & Services, 2018 to 2030 (USD Million)
  • 4.4. Kits & Reagents
    • 4.4.1. Kits & reagents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Enzymes
    • 4.5.1. Enzymes market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Instruments & Software
    • 4.7.1. Instruments & software market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Consumables
    • 4.8.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Nucleic Acid Methylation Market: Type Estimates & Trend Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. Global Nucleic Acid Methylation Market Type Movement Analysis
  • 5.3. Global Nucleic Acid Methylation Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. DNA Methylation
    • 5.4.1. DNA methylation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. RNA Methylation
    • 5.5.1. RNA methylation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Nucleic Acid Methylation Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Segment Dashboard
  • 6.2. Global Nucleic Acid Methylation Market Technology Movement Analysis
  • 6.3. Global Nucleic Acid Methylation Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
  • 6.4. Next-Generation Sequencing (NGS)
    • 6.4.1. Next-generation sequencing (NGS) market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Bisulfite Sequencing & PCR-based Techniques
    • 6.5.1. Bisulfite sequencing & pcr-based techniques market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Microarray-based Methylation Analysis
    • 6.6.1. Microarray-based methylation analysis market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Mass Spectrometry
    • 6.7.1. Mass spectrometry market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Hybridization-based & Antibody-based Detection
    • 6.8.1. Hybridization-based & antibody-based detection market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Nucleic Acid Methylation Market: Application Estimates & Trend Analysis

  • 7.1. Application Segment Dashboard
  • 7.2. Global Nucleic Acid Methylation Market Application Movement Analysis
  • 7.3. Global Nucleic Acid Methylation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 7.4. Drug Discovery & Personalized Medicines
    • 7.4.1. Drug discovery & personalized medicines market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Clinical Diagnostics
    • 7.5.1. Clinical diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Nucleic Acid Methylation Market: End Use Estimates & Trend Analysis

  • 8.1. End Use Segment Dashboard
  • 8.2. Global Nucleic Acid Methylation Market End Use Movement Analysis
  • 8.3. Global Nucleic Acid Methylation Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. Pharmaceutical & Biotechnology Companies
    • 8.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Academic & Research Institutes
    • 8.5.1. Academic & research institutes market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Hospitals & Diagnostic Laboratories
    • 8.6.1. Hospitals & diagnostic laboratories market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Nucleic Acid Methylation Market: Regional Estimates & Trend Analysis by Product & Services, Type, Technology, Application, and End Use

  • 9.1. Regional Market Share Analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 9.4. North America
    • 9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. U.S.
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. Canada
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.4. Mexico
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Europe
    • 9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. UK
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. Germany
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. France
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.5. Italy
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.6. Spain
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.7. Norway
      • 9.5.7.1. Key country dynamics
      • 9.5.7.2. Regulatory framework
      • 9.5.7.3. Competitive scenario
      • 9.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.8. Sweden
      • 9.5.8.1. Key country dynamics
      • 9.5.8.2. Regulatory framework
      • 9.5.8.3. Competitive scenario
      • 9.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.9. Denmark
      • 9.5.9.1. Key country dynamics
      • 9.5.9.2. Regulatory framework
      • 9.5.9.3. Competitive scenario
      • 9.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Asia Pacific
    • 9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Japan
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. China
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. India
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Australia
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. South Korea
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Thailand
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Latin America
    • 9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. Brazil
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. Argentina
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. MEA
    • 9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. South Africa
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.3. Saudi Arabia
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework
      • 9.8.3.3. Competitive scenario
      • 9.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.4. UAE
      • 9.8.4.1. Key country dynamics
      • 9.8.4.2. Regulatory framework
      • 9.8.4.3. Competitive scenario
      • 9.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.5. Kuwait
      • 9.8.5.1. Key country dynamics
      • 9.8.5.2. Regulatory framework
      • 9.8.5.3. Competitive scenario
      • 9.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company/Competition Categorization
  • 10.2. Strategy Mapping
  • 10.3. Company Market Position Analysis, 2024
  • 10.4. Company Profiles/Listing
    • 10.4.1. New England Biolabs
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. Thermo Fisher Scientific Inc.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Illumina Inc.
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Abcam plc
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Agilent Technologies Inc.
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. F. Hoffmann-La Roche Ltd
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Bio-Rad Laboratories, Inc.
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives
    • 10.4.8. QIAGEN
      • 10.4.8.1. Company overview
      • 10.4.8.2. Financial performance
      • 10.4.8.3. Product benchmarking
      • 10.4.8.4. Strategic initiatives
    • 10.4.9. Exact Sciences Corporation
      • 10.4.9.1. Company overview
      • 10.4.9.2. Financial performance
      • 10.4.9.3. Product benchmarking
      • 10.4.9.4. Strategic initiatives
    • 10.4.10. Diagenode Diagnostics S.A.
      • 10.4.10.1. Company overview
      • 10.4.10.2. Financial performance
      • 10.4.10.3. Product benchmarking
      • 10.4.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global nucleic acid methylation market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 4 Global nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 6 Global nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 8 North America nucleic acid methylation market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 10 North America nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 11 North America nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 12 North America nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 13 North America nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 14 U.S. nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 15 U.S. nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 16 U.S. nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 17 U.S. nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 18 U.S. nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Canada nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 20 Canada nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 21 Canada nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Canada nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 23 Canada nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Mexico nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 25 Mexico nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 26 Mexico nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Mexico nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 28 Mexico nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Europe nucleic acid methylation market, by country, 2018 - 2030 (USD Million)
  • Table 30 Europe nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 31 Europe nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 32 Europe nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Europe nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 34 Europe nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Germany nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 36 Germany nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 37 Germany nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Germany nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 39 Germany nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 40 UK nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 41 UK nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 42 UK nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 43 UK nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 44 UK nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 45 France nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 46 France nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 47 France nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 48 France nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 49 France nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Italy nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 51 Italy nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 52 Italy nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Italy nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 54 Italy nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Spain nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 56 Spain nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 57 Spain nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Spain nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 59 Spain nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Denmark nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 61 Denmark nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 62 Denmark nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Denmark nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 64 Denmark nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Sweden nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 66 Sweden nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 67 Sweden nucleic acid methylation market, by technology, 2018 - 2030 (USD Million
  • Table 68 Sweden nucleic acid methylation market, by application, 2018 - 2030 (USD Million
  • Table 69 Sweden nucleic acid methylation market, by end use, 2018 - 2030 (USD Million
  • Table 70 Norway nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 71 Norway nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 72 Norway nucleic acid methylation market, by technology, 2018 - 2030 (USD Million
  • Table 73 Norway nucleic acid methylation market, by application, 2018 - 2030 (USD Million
  • Table 74 Norway nucleic acid methylation market, by end use, 2018 - 2030 (USD Million
  • Table 75 Asia Pacific nucleic acid methylation market, by country, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific nucleic acid methylation market, by technology, 2018 - 2030 (USD Million
  • Table 78 Asia Pacific nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific nucleic acid methylation market, by application, 2018 - 2030 (USD Million
  • Table 80 Asia Pacific nucleic acid methylation market, by end use, 2018 - 2030 (USD Million
  • Table 81 China nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 82 China nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 83 China nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 84 China nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 85 China nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Japan nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 87 Japan nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 88 Japan nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 89 Japan nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 90 Japan nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 91 India nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 92 India nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 93 India nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 94 India nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 95 India nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 96 South Korea nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 97 South Korea nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 98 South Korea nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 99 South Korea nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 100 South Korea nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 101 Australia nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 102 Australia nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 103 Australia nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 104 Australia nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 105 Australia nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 106 Thailand nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 107 Thailand nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 108 Thailand nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 109 Thailand nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 110 Thailand nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 111 Latin America nucleic acid methylation market, by country, 2018 - 2030 (USD Million)
  • Table 112 Latin America nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 113 Latin America nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Latin America nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 115 Latin America nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 116 Latin America nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 117 Brazil nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 118 Brazil nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 119 Brazil nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 120 Brazil nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 121 Brazil nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 122 Argentina nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 123 Argentina nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 124 Argentina nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 125 Argentina nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 126 Argentina nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 127 MEA nucleic acid methylation market, by country, 2018 - 2030 (USD Million)
  • Table 128 MEA nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 129 MEA nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 130 MEA nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 131 MEA nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 132 MEA nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 133 South Africa nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 134 South Africa nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 135 South Africa nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 136 South Africa nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 137 South Africa nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 138 Saudi Arabia nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 143 UAE nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 144 UAE nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 145 UAE nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 146 UAE nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 147 UAE nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)
  • Table 148 Kuwait nucleic acid methylation market, by product & services, 2018 - 2030 (USD Million)
  • Table 149 Kuwait nucleic acid methylation market, by type, 2018 - 2030 (USD Million)
  • Table 150 Kuwait nucleic acid methylation market, by technology, 2018 - 2030 (USD Million)
  • Table 151 Kuwait nucleic acid methylation market, by application, 2018 - 2030 (USD Million)
  • Table 152 Kuwait nucleic acid methylation market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Nucleic acid methylation market: Market outlook
  • Fig. 5 Nucleic acid methylation market: Segment outlook
  • Fig. 6 Nucleic acid methylation market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Nucleic acid methylation market driver impact
  • Fig. 9 Nucleic acid methylation market restraint impact
  • Fig. 10 Nucleic acid methylation market: Product & services outlook and key takeaways
  • Fig. 11 Nucleic acid methylation market: Product & services movement analysis
  • Fig. 12 Kits & reagents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Enzymes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Instruments & software market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Nucleic acid methylation market: Type outlook and key takeaways
  • Fig. 18 Nucleic acid methylation market: Type movement analysis
  • Fig. 19 DNA methylation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 RNA methylation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Nucleic acid methylation market: Technology outlook and key takeaways
  • Fig. 22 Nucleic acid methylation market: Technology movement analysis
  • Fig. 23 Next-generation sequencing (NGS) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Bisulfite sequencing & PCR-based techniques market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 25 Microarray-based methylation analysis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Mass spectrometry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Hybridization-based & antibody-based detection market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Nucleic acid methylation market: Application outlook and key takeaways
  • Fig. 29 Nucleic acid methylation market: Application movement analysis
  • Fig. 30 Drug discovery & personalized medicines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Clinical diagnostics market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 32 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Nucleic acid methylation market: End use outlook and key takeaways
  • Fig. 34 Nucleic acid methylation market: End use movement analysis
  • Fig. 35 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Academic & research institutes market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Hospitals & diagnostic laboratories market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 38 Global nucleic acid methylation market: Regional outlook and key takeaways
  • Fig. 39 Global nucleic acid methylation market: Regional movement analysis
  • Fig. 40 North America nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Canada nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Germany nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 France nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Italy nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Norway nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 China nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Japan nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 India nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Middle East and Africa nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 UAE nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait nucleic acid methylation market estimates and forecasts, 2018 - 2030 (USD Million)